$HURC

HURCO (HURC) director Cynthia Dubin granted 5,432 common shares as compensation

HURCO Companies Inc. director Cynthia S. Dubin was granted 5,432 shares of common stock as compensation, as detailed in a recent SEC Form 4 filing. These shares were acquired at no purchase price, indicating an award, and bring her direct holdings to 25,049 common shares. The transaction, dated March 12, 2026, is classified as a non-derivative acquisition.

Original reporting
Published Mar 17, 2026, 7:09 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 17, 2026, 7:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$HURC
Bullish
medium confidence
Mentioned
$HURC
alphai data visualization · based on Stock Titan
Decision brief

The 30-second read

$HURCBullishMed
01

Why it matters

This insider activity may positively influence investor perception, potentially leading to short-term price appreciation.

02

Market read

The insider activity is relevant for traders focusing on HURC, especially those interested in insider signals and short-term trading opportunities.

03

What to watch

Market conditions, upcoming earnings reports, and broader economic indicators could offset the positive signal from insider activity.

Timing: High (transaction occurred on March 12, 2026, recent and relevant for immediate trading decisions)

Background

Cynthia S. Dubin, a director of HURCO Companies Inc., received 5,432 shares as compensation, indicating management's confidence.

Company-level read

Ticker impact

$HURCBullishMedium confidence
Context

The news pertains directly to HURC, the company's insider trading activity, which can influence investor perception and stock price.

Expected impact

Moderate upward price movement expected in the short term (1-3 weeks).

Evidence & confidence

Insider share grants often reflect management's confidence; however, the lack of recent earnings data limits the certainty of impact.

Market effects

Potential positive influence on the finance and corporate governance sectors due to insider confidence signals.

Limited; the news is specific to HURC and does not indicate broader regional market effects.

Negligible; insider transactions are company-specific and unlikely to affect global markets.

Counterpoint

Insider share grants can sometimes precede insider sales or negative developments; thus, this activity should not be solely relied upon for bullish positioning.

Key entities

  • Cynthia S. Dubin

    Director of HURCO Companies Inc., received stock grants as compensation.

  • HURCO Companies Inc.

    The company involved in the insider transaction.

Related articles

$HURCMed

HURCO COMPANIES INC (HURC): Results of Operations and Financial Condition

HURCO COMPANIES INC (HURC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ​ FOR IMMEDIATE RELEASE FRIDAY, SEPTEMBER 4, 2026 ​ HURCO REPORTS PROFIT IN THIRD QUARTER RESULTS FOR FISCAL YEAR 2026 ​ INDIANAPOLIS, INDIANA – September 4, 2026 -- Hurco Companies, Inc. (Nasdaq: HURC) today reported results for the third fiscal quarter ended July 3

$HURCMed

Hurco Companies, Inc.: Hurco Reports Profit in Third Quarter Results for Fiscal Year 2026

Hurco Companies (HURC) reported a net income of $2.3M ($0.35/Share) for Q3 2026, reversing a $3.7M loss from Q3 2025. Sales rose 3% to $47.3M, with orders up 25%. For 9M 2026, net loss narrowed to $3.5M ($0.55/Share) from $12.1M ($1.87/Share) in 2025. Sales grew 4% to $137.8M. CEO Greg Volovic attributed profitability to cost control, higher sales volumes, and tariff refunds. The company plans to introduce new technology at IMTS in Chicago.

$BKRMed

Baker Hughes Awarded Offshore Production Enhancement and Stimulation Services Contract by bp

Baker Hughes (BKR) secured a contract from bp (BP) to provide offshore stimulation services in the UK North Sea, supporting new well development and enhanced recovery. The deal involves a vessel-based solution for efficient well completions and production enhancement, aiming to improve operational reliability and reservoir recovery. Baker Hughes will leverage its StimFORCE modular stimulation package and local supply chain network.

$TEVAMed

S&P Global Ratings Upgrades Teva to BBB-, Marking Third Credit Rating Upgrade in Recent Months and Reflecting Strong Execution and Financial Discipline

S&P Global Ratings upgraded Teva Pharmaceutical's long-term issuer credit rating to BBB- from BB+, reflecting strong financial performance and debt reduction. This is the third upgrade in recent months, with Teva now holding investment-grade ratings from all major agencies. The company's CFO attributed the upgrades to successful execution of its growth strategy and improved financial profile.

$MOMOMed

StoneX cuts Hello Group stock price target on weaker outlook

StoneX reduced its price target for Hello Group (MOMO) to $8.00 from $10.00, citing weaker domestic spending and moderating overseas growth. The company's Q2 2026 revenue declined 5% YoY, though overseas revenue grew 52% YoY. StoneX lowered its fiscal 2026 revenue forecast to a 6% YoY decline. Hello Group's stock trades at $5.39, near its 52-week low, with a P/E ratio of 8.34 and a 5.1% dividend yield.

$NBISMedAI 8/10

Billionaire Stephen Mandel’s Top 2 AI Stock Picks

Billionaire Stephen Mandel's Lone Pine Capital opened new positions in Nebius Group (NBIS) and Seagate Technology (STX) in Q2. NBIS is the largest holding, with $1.18B invested, while STX saw $965.1M invested. NBIS reported a 454% revenue increase YoY to $582.3M, driven by high demand for AI cloud services. However, the company faces risks related to high capital expenditures and potential delays in data center construction.